Vascular leak is a central feature in the pathogenesis of systemic sclerosis

Journal of Rheumatology

Volumn 39, Issue 7, 2012, Pages 1385-1391

  Frech, Tracy M ^a   Revelo, Monica P ^a   Drakos, Stavros G ^a   Murtaugh, Maureen A ^a   Markewitz, Boaz A ^a   Sawitzke, Allen D ^a   Li, Dean Y ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Histopathology; Microscopy; Microvasculature; Scleroderma; Systemic sclerosis; Vasculopathy

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIGITAL IMAGING; DISEASE DURATION; FEMALE; HAND EDEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG EDEMA; MALE; MAST CELL; MICROSCOPY; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; PUNCH BIOPSY; RAYNAUD PHENOMENON; SKIN BIOPSY; SYSTEMIC SCLEROSIS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULAR DISEASE; VASCULAR LEAK;

ADULT; AGED; ANTIGENS, CD34; CAPILLARY LEAK SYNDROME; EDEMA; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MAST CELLS; MICROSCOPY; MICROVESSELS; MIDDLE AGED; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84863526680     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111380     Document Type: Article

References (47)

1. Chizzolini C, Brembilla NC, Montanari E, Truchetet ME. Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 2011;10:276-81.
2. Jinnin M. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol 2010;37:11-25.
3. Krieg T, Takehara K. Skin disease: A cardinal feature of systemic sclerosis. Rheumatology 2009;48 Suppl 3:iii14-8.
4. Pannu J, Trojanowska M. Recent advances in fibroblast signaling and biology in scleroderma. Curr Opin Rheumatol 2004;16:739-45. (Pubitemid 39425548)
5. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996;22:647-74. (Pubitemid 26396044)
6. Tuffanelli DL, Winkelmann RK. Systemic scleroderma. A clinical study of 727 cases. Arch Dermatol 1961;84:359-71.
7. Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology 2003;42:534-40. (Pubitemid 36432472)
8. Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc - Implications for vascular treatment strategies. Rheumatology 2008;47 Suppl 5:v18-20.
9. Maricq HR, Harper FE, Khan MM, Tan EM, LeRoy EC. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1983;1:195-205. (Pubitemid 14210276)
10. Cutolo M, Matucci Cerinic M. Nailfold capillaroscopy and classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:663-5. (Pubitemid 350284837)
11. Barnett AJ, Miller M, Littlejohn GO. The diagnosis and classification of scleroderma (systemic sclerosis). Postgrad Med J 1988;64:121-5. (Pubitemid 18068758)
12. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6. (Pubitemid 32660630)
13. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004;43:719-26. (Pubitemid 38807428)
14. Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 2006;45 Suppl 4:iv43-6. (Pubitemid 44446762)
15. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 2000;43:444-51. (Pubitemid 30395756)
16. Rodnan GP, Fennell RH Jr. Progressive systemic sclerosis sine scleroderma. JAMA 1962;180:665-70.
17. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001;60:585-91. (Pubitemid 32493985)
18. Steen VD, Medsger TA Jr, Rodnan GP. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): A retrospective analysis. Ann Intern Med 1982;97:652-9. (Pubitemid 13251633)
19. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T. Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol 1991;97:219-22.
20. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979;22:130-40. (Pubitemid 9156666)
21. Varga J, Abraham D. Systemic sclerosis: A prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67. (Pubitemid 46348510)
22. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998;25:84-8. (Pubitemid 28060123)
23. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
24. Mahoney WM Jr, Fleming JN, Schwartz SM. A unifying hypothesis for scleroderma: Identifying a target cell for scleroderma. Curr Rheumatol Rep 2011;13:28-36.
25. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996;98:785-92. (Pubitemid 26349184)
26. Norton WL, Hurd ER, Lewis DC, Ziff M. Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: Quantitative study of the microvascular bed. J Lab Clin Med 1968;71:919-33.
27. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992;166:255-63.
28. Hesselstrand R, Scheja A, Wildt M, Akesson A. High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology 2008;47:84-7. (Pubitemid 350286269)
29. Englert H, Low S. Pitting oedema in early diffuse systemic scleroderma. Ann Rheum Dis 2001;60:1079-80. (Pubitemid 32989188)
30. Pope J, McBain D, Petrlich L, Watson S, Vanderhoek L, de Leon F, et al. Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six-month, randomized, double-blind, placebo-controlled, proof-of-concept pilot study at a single center. Arthritis Rheum 2011;63:3547-51.
31. Brazdziute E, Laurinavicius A. Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring. Diagn Pathol 2011;6 Suppl 1:S5.
32. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, et al. Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol 2010;56:382-91.
33. Wilbur DC. Digital cytology: Current state of the art and prospects for the future. Acta Cytol 2011;55:227-38.
34. Pots S. Angiogenesis measurement using digital pathology. Lab Medicine 2008;39:265-71.
35. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
36. Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011;40:78-83.
37. Oteiza A, Li R, McCuskey RS, Smedsrod B, Sorensen KK. Effects of oxidized low-density lipoproteins on the hepatic microvasculature. Am J Physiol Gastrointest Liver Physiol 2011;301:G684-93.
38. Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MI. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: Direct evidence for a generalized microangiopathy. Br J Dermatol 1992;126:561-8.
39. Frieri M. Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 1992;69:385-92, 395-6.
40. Claman HN. Mast cell changes in a case of rapidly progressive scleroderma - Ultrastructural analysis. J Invest Dermatol 1989;92:290-5. (Pubitemid 19061276)
41. Krause DS, Fackler MJ, Civin CI, May WS. CD34: Structure, biology, and clinical utility. Blood 1996;87:1-13. (Pubitemid 26018389)
42. Nielsen JS, McNagny KM. Novel functions of the CD34 family. J Cell Sci 2008;121:3683-92.
43. Cotran RS, Pober JS, Gimbrone MA Jr, Springer TA, Wiebke EA, Gaspari AA, et al. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. J Immunol 1988;140:1883-8.
44. von Bierbrauer A, Barth P, Willert J, Baerwald C, Mennel HD, Schmidt JA. Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: Detection of ultrastructural changes of the microcirculatory vessels. Br J Rheumatol 1998;37:1272-8.
45. Kahaleh B. Vascular disease in scleroderma: Mechanisms of vascular injury. Rheum Dis Clin North Am 2008;34:57-71; vi.
46. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, Scott F, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011;146:980-91.
47. Hawkins RA, Claman HN, Clark RA, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis? Ann Intern Med 1985;102:182-6. (Pubitemid 15157165)